Pmv Pharmaceuticals Inc (PMVP) Stock Analysis

Pmv Pharmaceuticals Inc (PMVP) is a publicly traded company in the HEALTHCARE sector. It trades at $1.18, carries a market capitalization of $65.60M. This page summarizes the public market data, fundamentals, and frequently asked questions for PMVP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Pmv Pharmaceuticals Inc currently has a Bullish sentiment score of 0.18.

About Pmv Pharmaceuticals Inc

PMV Pharmaceuticals, Inc. is an innovative precision oncology company headquartered in Cranbury, New Jersey, dedicated to the discovery and development of targeted small molecule therapies aimed at p53 mutations found in a range of cancers. By harnessing cutting-edge technology and in-depth insights into tumor biology, PMV seeks to transform cancer treatment paradigms with tumor-agnostic therapies, thus addressing significant unmet medical needs. The company's strategic focus on novel therape...

GNG Research Analysis

GNG Research scores Pmv Pharmaceuticals Inc (PMVP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PMVP.

Frequently Asked Questions

Does PMVP pay dividends?

Pmv Pharmaceuticals Inc (PMVP) does not currently pay a regular dividend.

What is PMVP's market cap?

Pmv Pharmaceuticals Inc (PMVP) has a market capitalization of $65.60M with a current stock price of $1.18.